Views & Analysis The shadow of Brexit on speed of access No-one can miss the ongoing saga that is the UK’s exit from the European Union (EU).
News Bayer trial combines two top drugs for kidney disease Data from the CONFIDENCE trial shows the value of combining Bayer's Kerendia with an SGLT2 inhibitor to treat chronic kidney disease in diabetics.
